HLS is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties.
|Vascepa||CV risk reduction||Canada||Marketed|
|Trinomia||CV risk reduction||Canada||Under review|
|CENTRAL NERVOUS SYSTEM (CNS)|
|CSAN Pronto||WBC Point-of-Care Diagnostic||Canada||Marketed|
|PERSERIS||Schizophrenia||Canada||Approved and in pre-launch phase|
|MyCare Psychiatry / MyCare Insite||Psychiatric Therapeutic Drug Monitoring||Canada||Approved and in pre-launch phase / under review|
|Royalty Portfolio||Multiple Indications||Global||Marketed by third parties|
For U.S. Residents, click here for commercial product information.
For Canadian Residents, please click on the Canadian flag above for more commercial product information.